Honest Health helps health systems and providers manage value-based care through care coordination, clinical insights and operational support.
Startup Funding News
New startup rounds, lead investors and the businesses behind the funding.
6 rounds · $396.4M disclosed · $52.5M median
| Company | Amount | Stage / sector | Lead investor | Announced |
|---|---|---|---|---|
| Honest Health Honest Health helps health systems and providers manage value-based care through care coordination, clinical insights and operational support. | $140M | Undisclosed Healthtech | NewSpring Healthcare | |
| Salma Health Salma Health operates brain-health clinics combining diagnostics, psychiatric treatment, intensive outpatient care and clinical research. | $80M | Series A Healthcare | Mubadala Capital, ARCH Venture Partners | |
| Slate Medicines Slate Medicines develops treatments to prevent migraines and other headache disorders, led by an antibody targeting PACAP. | $130M | Series A Biotech | RA Capital Management, Forbion, Foresite Capital | |
| Madeed A preventive health membership combining blood and biomarker tests, clinician-reviewed results and personalised nutrition and supplement plans for members in Saudi Arabia. | $400K | Pre-seed Healthcare | Vision Ventures | |
| Engitix Engitix develops cancer and fibrosis therapies that target the extracellular matrix surrounding cells in diseased tissue. | $25M | Series A Biotech | — | |
| Luminate Medical Luminate Medical develops services and devices for home cancer treatment and for reducing chemotherapy side effects. | $21M | Series A Medtech | ARTIS Ventures, Lachy Groom |
Salma Health operates brain-health clinics combining diagnostics, psychiatric treatment, intensive outpatient care and clinical research.
Slate Medicines develops treatments to prevent migraines and other headache disorders, led by an antibody targeting PACAP.
A preventive health membership combining blood and biomarker tests, clinician-reviewed results and personalised nutrition and supplement plans for members in Saudi Arabia.
Engitix develops cancer and fibrosis therapies that target the extracellular matrix surrounding cells in diseased tissue.
Luminate Medical develops services and devices for home cancer treatment and for reducing chemotherapy side effects.
Reports & briefings
September 2026 Startup Funding Report
77 sourced rounds, with company profiles and participating investors.
Sep 21 – 27, 2026 Startup Funding Weekly
27 sourced rounds, with company profiles and participating investors.
Sep 14 – 20, 2026 Startup Funding Weekly
5 sourced rounds, with company profiles and participating investors.
Active investors
| Investor | Rounds | Led | Recent investments |
|---|---|---|---|
| 01Lightspeed Venture Partners | 23 | 6 | Temporal TechnologiesNeko Health |
| 02Y Combinator | 22 | 1 | SpottConveo |
| 03Andreessen Horowitz | 21 | 7 | ArmadinEliseAI |
| 04Accel | 21 | 6 | ArmadinEma |